This inventor holds 1 USPTO granted patent. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Rashminkumar Rameshchandra Pandya: Innovator in Dermatological Treatments
Introduction
Rashminkumar Rameshchandra Pandya is a notable inventor based in Vadodara, India. He has made significant contributions to the field of dermatology, particularly in the treatment of skin conditions such as acne and psoriasis. His innovative approach has led to the development of a unique formulation that addresses common issues associated with existing treatments.
Latest Patents
Rashminkumar holds a patent for "Tazarotene with low dimer impurity for treating acne or psoriasis." This invention focuses on a method of treating these skin conditions by topically administering Tazarotene that is substantially free of dimer impurity. The specific formula involved is 4,4-dimethyl-6-[4-(4,4-dimethylthiochroman-6-yl)-buta-1,3-diynyl]-thiochroman. This advancement is crucial for improving the efficacy and safety of acne and psoriasis treatments.
Career Highlights
Rashminkumar is currently associated with Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Sun Pharmaceutical has allowed him to collaborate with other talented professionals in the field, enhancing the development of innovative treatments.
Collaborations
Some of his notable coworkers include Rajeev Budhdev Rehani and Rajamannar Thennati. Their collective expertise contributes to the advancement of pharmaceutical innovations and the development of effective treatment options.
Conclusion
Rashminkumar Rameshchandra Pandya's contributions to dermatological treatments exemplify the impact of innovation in healthcare. His patent for Tazarotene with low dimer impurity represents a significant step forward in treating acne and psoriasis effectively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
